Skip to main content
. Author manuscript; available in PMC: 2017 Mar 31.
Published in final edited form as: J AAPOS. 2016 Jul 12;20(4):326–331. doi: 10.1016/j.jaapos.2016.05.014

Table 2.

Comparison with prior IO-Therapy studies

Spierer et al12
(2010)
Erbagci et al13
(2015)
Our study
Study design No control group No control group Clinical trial with patching control group
Sample size 24 14 19 IO vs 15 Patch
Age at treatment (years) 4–7.8 4.5–10 3–8
Patients characteristics Moderate amblyopia, previously treated or untreated Moderate and severe amblyopia, previously untreated, no optical correction adaptation period Moderate amblyopia, previously untreated, optical correction adapted,
IO-Therapy glasses occlusion setting 40 seconds on and 20 seconds off 30 seconds on and 30 seconds off 30 seconds on and 30 seconds off
Daily IO-Therapy hours At least 8 hours 4–12 hours 4 hours
Reported follow-up period (months) 1.5, 3, 4.5, 6, 9 3 to 7 (mean 4.0±1.2) 3
Visual acuity improvement (logMAR) 0.16±0.3 (at 3-months) 0.3±0.2 0.15±0.12